Entre o direito e a inovação: a celeridade processual como elemento primordial ao estímulo à P, D&I para doenças negligenciadas e as medidas adotadas pelo INPI no combate ao backlog de patentes
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Globalization and technological progress have led to an increase in complex inventions,
intensifying the demand for intellectual property rights. This creates challenges in patent
offices, which cannot process all requests in an agile and swift manner, especially in Brazil,
which has the largest patent backlog in the world. Consequently, the unreasonable delay in
analyzing requests impedes the realization of the patent system, insofar as the efficiency of the
bodies responsible for the examination and granting of exclusivity is crucial to foster innovation
and economic development. This fact is even more worrying concerning neglected diseases,
which do not have a large volume of inventions, and, the few that are developed, are subject to
the unwarranted slowness of examiners. To reverse this problem, the INPI has been building,
since 2013, policies for prioritizing patent applications to expedite the analysis of certain
processes, among which are the diseases mentioned above. In this context, the present study
seeks to ascertain what the data collected at INPI related to patents granted for neglected
diseases reveal about the performance of measures to prioritize the processing of patent
applications for these diseases. The theoretical-methodological reference consists of the
Bankowskian distinction between duty morality and aspiration morality, as well as the rules of
inference proposed by Epstein and King. In general terms, it was observed that the priority
processing established by the INPI seems to have a positive impact, reducing the average time
for granting the patent. However, more people, individuals or corporations, beneficiaries of
this agility must make use of the benefit, to verify if the reduction of the analysis time is
maintained when there is an increase in the number of requests with priority. On the other
hand, there are indications that INPI's previous approach, through priority examination, did
not achieve the objective proposed by the agency. Finally, the present analysis found that there
are a reduced number of patents granted for neglected diseases, indicating an imbalance in the
patent legal system. In addition, these inventions are restricted to the public sector,
demonstrating the need to rethink the national innovation policy.
Description
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Embargado

